CAVALLO PERIN, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 14.577
EU - Europa 9.374
AS - Asia 3.973
SA - Sud America 114
OC - Oceania 87
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 12
Totale 28.194
Nazione #
US - Stati Uniti d'America 14.307
DK - Danimarca 3.065
CN - Cina 2.031
IT - Italia 1.191
IE - Irlanda 871
SG - Singapore 795
DE - Germania 787
FR - Francia 690
SE - Svezia 643
FI - Finlandia 513
UA - Ucraina 441
KR - Corea 430
GB - Regno Unito 340
AT - Austria 245
PL - Polonia 244
CA - Canada 235
VN - Vietnam 154
JP - Giappone 103
ID - Indonesia 90
IN - India 89
AU - Australia 72
ES - Italia 66
BR - Brasile 61
NL - Olanda 45
TR - Turchia 45
BE - Belgio 44
TW - Taiwan 44
HK - Hong Kong 41
RU - Federazione Russa 37
CH - Svizzera 31
IR - Iran 25
MX - Messico 24
PH - Filippine 23
TH - Thailandia 22
SN - Senegal 20
MY - Malesia 19
GR - Grecia 18
NZ - Nuova Zelanda 15
CO - Colombia 14
NO - Norvegia 14
UZ - Uzbekistan 14
PE - Perù 13
AR - Argentina 12
RO - Romania 12
EU - Europa 11
PT - Portogallo 11
HU - Ungheria 10
BY - Bielorussia 8
IQ - Iraq 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
EG - Egitto 7
BG - Bulgaria 6
CL - Cile 6
IL - Israele 6
PK - Pakistan 5
RS - Serbia 5
EE - Estonia 4
KE - Kenya 4
LT - Lituania 4
MA - Marocco 4
MK - Macedonia 4
NG - Nigeria 4
ZA - Sudafrica 4
DZ - Algeria 3
JM - Giamaica 3
LU - Lussemburgo 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
IM - Isola di Man 2
IS - Islanda 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
Totale 28.181
Città #
Ann Arbor 4.819
Beijing 1.312
Chandler 1.098
Dublin 859
Singapore 638
Houston 579
Santa Clara 528
Wilmington 492
Ashburn 482
Villeurbanne 419
Fairfield 370
Jacksonville 364
Princeton 351
Dearborn 331
Woodbridge 317
Medford 272
Vienna 242
Nyköping 231
Warsaw 220
Columbus 214
Seattle 209
Redwood City 201
Torino 182
Munich 151
Milan 129
Cambridge 128
Fremont 127
Boston 119
Pisa 111
Dong Ket 107
Montréal 104
Palaiseau 94
Grafing 84
Boardman 72
Guangzhou 60
Hefei 60
Shanghai 59
Menlo Park 56
New York 54
Toronto 53
Jakarta 50
Verona 50
Nanjing 46
Hangzhou 44
Kunming 41
Düsseldorf 40
Rome 40
Norwalk 39
Falls Church 36
Turin 34
Los Angeles 32
Brussels 31
Helsinki 31
San Diego 31
Phoenix 28
Nanchang 27
Taipei 27
Tokyo 24
Mountain View 23
Jinan 22
London 22
Des Moines 20
Lachine 20
Changsha 19
Chengdu 19
Wuhan 19
Central District 18
Detroit 18
Ottawa 18
Padova 18
Pune 18
Washington 17
Istanbul 16
Silver Spring 16
Stockholm 16
Zhengzhou 16
Chongqing 15
Bologna 14
Duncan 14
Frankfurt am Main 14
Hanoi 14
Lima 13
Madrid 13
Sydney 13
Edinburgh 12
Kuala Lumpur 12
San Francisco 12
Shenyang 12
Chicago 11
Hebei 11
Zurich 11
Fuzhou 10
Moscow 10
San Mateo 10
Trieste 10
Costa Mesa 9
Hong Kong 9
São Paulo 9
Tianjin 9
Amsterdam 8
Totale 17.559
Nome #
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial 781
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 460
Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes 453
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 429
Impact of Snacking Pattern on Overweight and Obesity Risk in A Cohort of 11-13-y Adolescents 423
Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy) 363
Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato survey, Italy. 347
Joint use of cardio-embolic and bleeding risk scorers in elderly patients with atrial fibrillation. 305
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy 294
Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. 292
Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study 258
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort. 257
Direct costs of diabetic and non diabetic people: the population-based Turin study. 249
Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. 241
NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study 237
The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study 233
Serum levels of heat shock protein 27 in patients with acute ischemic stroke 220
Activated protein C resistance in type I diabetes. 212
What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients 203
Effetti dello stress meccanico (stretch) combinato all’alto glucosio sulla proliferazione, l’apoptosi e la morfologia dei periciti retinici. 203
Association between serum heat shock proteins and anti-heat shock proteins levels with micro/macrovascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study 197
Albumin excretion rate is not increased in atherosclerotic patients with peripheral vascular disease. 196
Urinary exosomal microRNA signature in incipient diabetic nephropathy 195
N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. 195
Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study 194
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study 194
MORTALITY OUTCOMES OF DIFFERENT SULFONYLUREA DRUGS. The results of a 14-year cohort study of type 2 diabetic patients 193
Monocyte Chemoattractant Protein-1 (MCP-1) has direct prosclerotic effects in human mesangial cells 192
Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma 191
Silicone lymphadenopathy after silent Silicone breast implant rupture 191
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy 190
Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study 190
Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. 189
Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria 186
Effetti dello stress meccanico (stretch) sulla proliferazione cellulare nei periciti retinici bovini in alto glucosio. 185
Effects of mechanical stress and high glucose on pericyte proliferation, apoptosis and contractile phenotype 185
Ruolo protettivo del recettore CB2 nella nefropatia diabetica sperimentale 185
Apolipoprotein H is increased in type 2 diabetic patients with microalbuminuria. 185
Protective role of cannabinoid receptor type-2 in a mouse model of diabetic nephropathy 184
Il sistema MCP-1/CCR2 nelle cellule mesangiali umane: modulazione da stretch e ruolo nell’espressione di ICAM-1 183
Anticoagulant protein C in type II diabetic patients with and without microalbuminuria 182
Espressione delle proteine dello slit DIAPHRAGM in animali diabetici knockout per il monocyte chemoattractant protein-1. 182
Urinary excretion of glycated albumin in insulin-dependent diabetic patients with micro- and macroalbuminuria. 179
Early life socioeconomic indicators and the risk of type 1 diabetes in children and young adults 179
Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study 178
Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes 176
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 176
Albumin excretion rate in non diabetic offspring of type 2 diabetic patients 175
The glucoregulatory and antilipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study. 175
ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE 174
Retinal heat shock protein 25 in early experimental diabetes 173
Increased QT interval dispersion predicts 15-years cardiovascular mortality in type 2 diabetic subjects. The population-based Casale Monferrato Study 171
Lipoprotein(a) after acute exercise in healthy subjects. 170
Effetti dello stress meccanico(stretch) combinato con l’alto glucosio sulla proliferazione, l’apoptosi e la morfologia dei periciti retinici. 168
Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. 168
The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells 167
Effect of CB2 Receptor Activation in Experimental Diabetic Nephropathy 167
Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study 166
Effects of mechanical stress (stretch) combined with high glucose on retinal pericyte replication, apoptosis and morphology. 166
Increased retinal HSP27 expression in early experimental diabetes 166
High-normal blood pressure and impaired renal function. A prospective study in a population-based cohort. 166
Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice 165
The Monocyte Chemoattractant Protein-1/Cognate CC Chemokine Receptor 2 System Affects Cell Motility in Cultured Human Podocytes 164
Increased levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria 164
Trombomodulin is increased in microalbuminuric insulin dependent diabetic patients 164
Effects of CB1 Blockade In Experimental Diabetic Nephropathy 163
Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells 162
Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the Eurodiab Prospective Complications Study 161
Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. 161
Heat shock protein expression in early diabetic nephropathy 161
Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale 161
Thrombomodulin levels in insulin-dependent diabetic patients with microalbuminuria 160
Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy 159
Effects of mechanical stress (stretch) combined with high glucose on retinal pericyte replication, apoptosis and morphology. 159
NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α 159
Serum glucose, insulin, C-peptide and plasma glucagon response to oral glucose after intravenous injection of different glucocorticoids at increasing doses in man 159
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy. 158
Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity. 157
PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria 157
Electrocardiographic left ventricular hypertrophy in type 1 diabetes. Prevalence and relation to coronary heart disease and cardiovascular risk factors: The Eurodiab IDDM Complications Study 156
Microalbuminuria and plasma endothelin-1 in non insulin dependent diabetes mellitus 156
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. 155
N-terminal pro-brain natriuretic peptide and cardiovascular mortality in type 2 diabetes: the Casale Monferrato survey. 155
Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man 154
QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study 154
Coagulation inhibitors in type 2 diabetic patients with and without microalbuminuria 153
The MCP-1/CCR2 system in human mesangial cells: modulation by stretch and role in ICAM-1 expression 152
Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone 152
The rs553668 polymorphism of ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study 151
La dolce Vita. Per un Museo del Diabete. FONDAZIONE DIABETE TORINO - ONLUS 151
Heat shock protein expression in diabetic nephropathy 150
Microalbuminuria in insulin-dependent diabetes is associated with high levels of prothrombin fragment 1 + 2 149
Lipoprotein(a) in non-insulin-dependent diabetic patients with normo- and microalbuminuria 149
Haemostatic alterations in microalbuminuric insulin dependent diabetic patient 148
Plasma beta-thromboglobulin and platelet factor 4 are not increased in insulin-dependent diabetic patients with microalbuminuria 148
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology 147
Microalbuminuria in insulin-dependent diabetes is associated with monocyte procoagulant activity 147
Il blocco del recettore CB1 nella nefropatia diabetica sperimentale 146
Coma nel diabetico 143
Lipoprotein(a) and insulin treatment in non insulin dependent diabetic patients 141
Totale 19.935
Categoria #
all - tutte 72.018
article - articoli 0
book - libri 0
conference - conferenze 17.698
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.094 0 0 0 0 0 1.161 486 208 229 424 775 811
2020/20212.832 651 97 138 93 190 138 175 89 291 202 105 663
2021/20225.951 587 467 512 731 456 499 630 558 404 99 424 584
2022/20233.786 554 195 58 285 337 970 394 292 353 59 229 60
2023/20241.537 180 223 70 86 98 203 47 195 17 102 113 203
2024/20252.005 48 200 110 368 1.078 201 0 0 0 0 0 0
Totale 29.323